Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT07242651
Starting soon Not applicable

Tension and Trauma Releasing Exercises on Hypertensive Patients

NCT07242651 · tracked via the Priya Life Science Egypt tracker
Sponsor
Cairo University
Phase
Not applicable
Started
2025-11-18
Last updated
2025-11-21

Condition(s) studied

Hypertension (HTN)

Investigational drug(s) / intervention(s)

Tension and trauma releasing exercises

Tension and trauma releasing exercises: Tension and trauma releasing exercises will be conducted for study group only as follows: The exercises start by slightly fatiguing specific muscle groups to encourage this involuntary shaking, which is considered healthy and calming. The first exercise: Feet roll gently outward while shifting weight side to side, helping release ankle tension. The second exercise: One foot steps back while the front heel lifts until the calf feels lightly tired, triggering a small shake. The third exercise: A small lunge-like position engages the thighs and hips, leading to natural muscle release. The fourth exercise: A soft bend at the hips with relaxed arms and deep breathing stretches the back and encourages loosening. The fifth exercise: With feet wide and hands on the lower back, the hips push forward slightly while breathing deeply and turning gently side to side. The sixth exercise: The body slides into a seated position against a wall to lightly fatigue the

Study summary

The aim of this study is to investigate the effect of Tension and Trauma Releasing Exercises (TRE) on the quality of life and sleep in hypertensive patients. Participants will perform a series of supervised TRE sessions, and their sleep quality, and quality of life will be assessed before and after the intervention to determine any potential improvements related to the exercise.

Eligibility

Sex
FEMALE
Min age
50 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: 1. Participants will be between 50 and 65 years of age. 2. The BMI of patients will range between 30 and 34.9. 3. Patients included in the study were diagnosed with essential hypertension for at least five years. 4. The patients will be in stage 1 hypertension under medical control, characterized by systolic blood pressure ranging from 140 to 159 mmHg and diastolic blood pressure ranging from 90 to 99 mmHg. Exclusion Criteria: 1. Patients suffering from any unstable cardiovascular condition, such as uncontrolled arrhythmias or recent myocardial infarction. 2. Patients are diagnosed with secondary hypertension. 3. Patients with cognitive or physical impairments that prevent them from following instructions. e) Patients who are taking beta-blockers and alpha-blockers because these medications may affect heart rate. f) Individuals with endocrine disorders or any condition known to influence hormonal levels. g) Patients are smokers. h) Malignant hypertension.

Primary outcome measure(s)

  • Quality of life ,assessed by SF12 — Baseline and after 8 weeks of intervention
    Change in SF-12 physical and mental component summary scores from baseline to 8 weeks.
  • Sleep quality, assessed by the Pittsburgh Sleep Quality Index (PSQI). — Baseline and 8 weeks after the start of the intervention
    Change in global PSQI score from baseline to 8 weeks. PSQI will be administered to assess sleep quality .

Trial sites (1)

FacilityCityRegionStatus
Faculty of physical therapy ,Cairo University Giza Egypt

More Cairo University trials in Egypt

Metabolic Effectiveness of Extracorporeal Shockwave on Abdominal Adiposity Enrolling by invitation
Clinical and Radiographic Evaluation of Calcium Hypochlorite Versus Saline As Root Canal Irrigants in Pulpectomy of Primary Molars: a Randomized Clinical Trial Starting soon
Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis Starting soon
Effect of Breather in COPD Patients With Intermittent Claudication Recruiting
Music Effect on Concentration and Gait in Cerebral Palsy Children During Physical Therapy Sessions Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07242651 on ClinicalTrials.gov ↗ ← All trials in Egypt